论文部分内容阅读
目的研究静脉点滴巴曲酶（ＤＦ－５２１）对急性脑血栓患者纤维蛋白溶解系统的影响。方法用美国ＰａｃｉｆｉｃＨｅｍｏｓｔａｓｉｓ公司提供的Ｄ－二聚体测定试剂盒，对４３例急性脑血栓患者治疗前后血浆中Ｄ－二聚体含量进行了检测并与脑血栓后遗症患者和正常人作对照。结果静点该药后，急性脑血栓患者血浆Ｄ－二聚体明显上升。结论ＤＦ－５２１使纤溶系统进一步活跃，加速了溶解血栓的作用
Objective To investigate the effect of intravenous drip batroxobin (DF-521) on fibrinolytic system in patients with acute cerebral thrombosis. Methods Plasma D-dimer levels in 43 patients with acute cerebral thrombosis before and after treatment were measured by D-dimer assay kit supplied by Pacific Hemostasis Company and compared with patients with cerebral thrombosis and normal subjects. Results After intravenous injection of the drug, plasma D-dimer in patients with acute cerebral thrombosis was significantly increased. Conclusion DF-521 further fibrinolytic system accelerated the role of thrombolysis